Integer Holdings ITGR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Sales by Product | ||||||
| Cardiac Rhythm Management & Neuromodulation | $676.72M+1.2% | $668.8M-0.5% | $672.02M+0.6% | $667.96M+0.6% | $664.02M+0.5% | |
| Other Markets | $69.16M-11.1% | $77.75M-3.9% | $80.88M-4.6% | $84.81M-11.3% | $95.57M-10.2% | |
| Long-Lived Assets by Geography | ||||||
| Ireland | $633.3M+1.6% | $623.46M+3.4% | $602.83M— | —— | —— | |
| Mexico | $176.21M+4.2% | $169.07M+5.0% | $160.99M— | —— | —— | |
| Rest of world | $124.12M+0.5% | $123.5M+4.0% | $118.8M— | —— | —— | |
| United States | $1.16B+1.7% | $1.15B+3.4% | $1.11B— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Integer Holdings break its business down?
- Integer Holdings (ITGR) reports total sales by product across 3 parts — Cardiac Rhythm Management & Neuromodulation, Cardio & Vascular and Other Markets. Each is extracted from the segment footnotes and tracked over time.
- Where does Integer Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Integer Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.